2nd Quarter - Amendment

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$1,840,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 19, 2016 $1,840,000 Replaced
2nd Quarter - Amendment Oct 19, 2016 $1,840,000 Replaced
2nd Quarter - Amendment (this page) Jun 14, 2017 $1,840,000 Yes

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Hospital discounts; 340B Program

LobbyistCovered position, as disclosed
SEAN DONOHUE —

Contacted: SENATE; Justice, Dept of (DOJ); U.S. Trade Representative (USTR); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Manufacturing MAN

Prior user rights

LobbyistCovered position, as disclosed
BRUCE ARTIM —

Contacted: Natl Institutes of Health (NIH); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Homeland Security, Dept of (DHS); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Commerce, Dept of (DOC)

Trade (domestic/foreign) TRD

Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Justice, Dept of (DOJ); U.S. Trade Representative (USTR)

Agriculture AGR

Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling

LobbyistCovered position, as disclosed
ANJULEN ANDERSON REILLY —
JESSE SEVCIK —
ERIC J. STEINER —

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Natl Institutes of Health (NIH); State, Dept of (DOS); Justice, Dept of (DOJ); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); SENATE

Taxation/Internal Revenue Code TAX

Tax reform

LobbyistCovered position, as disclosed
ANJULEN ANDERSON REILLY —
BRUCE ARTIM —
JESSE PRICE —

Contacted: Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Intellectual property; MODDERN Cures

LobbyistCovered position, as disclosed
BRUCE ARTIM —
JESSE PRICE —
SONYA SOTAK ELLING —

Contacted: Office of Management & Budget (OMB); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); SENATE; Justice, Dept of (DOJ); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Patent protection; Drug shortages; Drug Pricing and Value; Dormant Therapies Act; PPACA; 21st Century Cures; Innovations for Healthier Americans

LobbyistCovered position, as disclosed
BRUCE ARTIM —
SEAN DONOHUE —
JOE KELLEY —

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS)

Medicare/Medicaid MMM

Intellectual Property; MODDERN Cures; Dormant Therapies; 21st Century Cures; 340B Program; Part B

LobbyistCovered position, as disclosed
SEAN DONOHUE —
JESSE PRICE —
JENNIFER ROMANS New Health Policy Advisor, Majority Leader Bill Frist (R-TN) Senior Health Policy Advisor, Senator Jon Kyl (R-AZ)
SONYA SOTAK ELLING —

Contacted: Justice, Dept of (DOJ); SENATE; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Consumer Issues/Safety/Products CSP

Anti-counterfeiting; Patient safety; Drug pedigree, serialization and traceability issues; Drug Quality and Security Act; Protecting Consumers from Illegal Online Drug Sales; Online Pharmaceutical Safety Act; Promoting Public-Private Partnerships

LobbyistCovered position, as disclosed
BRUCE ARTIM —
JESSE PRICE —
JEANNIE SALO —

Contacted: Justice, Dept of (DOJ); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR)

Torts TOR

Trade secret/theft protection coalition

LobbyistCovered position, as disclosed
BRUCE ARTIM —

Contacted: Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Institutes of Health (NIH); SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.